Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Lampalizumab Biosimilar – Anti-CFD mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | Fab'-G1-kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Lampalizumab Biosimilar - Anti-CFD mAb - Research Grade |
|---|---|
| Source | CAS 1278466-20-8 |
| Species | Humanized |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Lampalizumab,AFD, Anti-fD,Anti-FACTOR D,FCFD4514S,RG7417,CFD,anti-CFD |
| Reference | PX-TA1295 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | Fab-G1-kappa |
| Clonality | Monoclonal Antibody |
Description of Lampalizumab Biosimilar - Anti-CFD mAb - Research Grade
General information on Anti-CFD[Homo sapiens] (Lampalizumab) Monoclonal Antibody
Lampalizumab has been investigated for the treatment of Geographic Atrophy.
Related products
Antigen
CFD, N-His, recombinant protein
PX-P5643 392$Contact us
Send us a message from the form below
Reviews
There are no reviews yet.